Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV

Journal Article · · Virology
OSTI ID:21460261
 [1];  [2];  [3];  [1]
  1. Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas St., Charleston, SC 29425 (United States)
  2. Department of Craniofacial Biology, Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas St., Charleston, SC 29425 (United States)
  3. Department of Cell and Molecular Pharmacology, Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas St., Charleston, SC 29425 (United States)
The Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS), an important cause of morbidity and mortality in immunocompromised patients. KSHV interaction with the cell membrane triggers activation of specific intracellular signal transduction pathways to facilitate virus entry, nuclear trafficking, and ultimately viral oncogene expression. Extracellular heat shock protein 90 localizes to the cell surface (csHsp90) and facilitates signal transduction in cancer cell lines, but whether csHsp90 assists in the coordination of KSHV gene expression through these or other mechanisms is unknown. Using a recently characterized non-permeable inhibitor specifically targeting csHsp90 and Hsp90-specific antibodies, we show that csHsp90 inhibition suppresses KSHV gene expression during de novo infection, and that this effect is mediated largely through the inhibition of mitogen-activated protein kinase (MAPK) activation by KSHV. Moreover, we show that targeting csHsp90 reduces constitutive MAPK expression and the release of infectious viral particles by patient-derived, KSHV-infected primary effusion lymphoma cells. These data suggest that csHsp90 serves as an important co-factor for KSHV-initiated MAPK activation and provide proof-of-concept for the potential benefit of targeting csHsp90 for the treatment or prevention of KSHV-associated illnesses.
OSTI ID:
21460261
Journal Information:
Virology, Journal Name: Virology Journal Issue: 1 Vol. 403; ISSN VIRLAX; ISSN 0042-6822
Country of Publication:
United States
Language:
English

Similar Records

KSHV vIRF4 enhances BCL6 transcription via downregulation of IRF4 expression
Journal Article · Wed Feb 14 23:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23127369

Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus
Journal Article · Mon Nov 14 23:00:00 EST 2005 · Experimental Cell Research · OSTI ID:20717687

Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA
Journal Article · Wed Aug 01 00:00:00 EDT 2007 · Virology · OSTI ID:20977045